Table of Contents
Antidepressants Plus Psychotherapy no More Effective for Chronic DepressionReview of MRI Studies Evaluates Impact of Antipsychotics on Brain StructureMyxedema Coma Secondary to Aripiprazole and SertralineMemantine Add-On to Clozapine for Treatment-Refractory SchizophreniaWhen Received Wisdom Fails: Psychotherapy for Treatment-Resistant DepressionEffects of Antipsychotics on Brain StructureOpen-Label Study of Escitalopram for OCDAripiprazole as Add-On to Risperidone or Quetiapine for SchizophreniaVocal Tics with ZiprasidoneApprovals: Seroquel XR as Add-On Treatment to Antidepressants in MDDApprovals: Seroquel for Pediatric Schizophrenia and Bipolar I DisorderApprovals: Zyprexa for Schizophrenia and Bipolar I Disorder in Adolescents (Source: The Brown University Psychopharmacology Update)div id=medwormpbiMedWorm Message:/i/b Find the best a href=http://www.januarysales.org/ target=_blankJanuary Sales/a in the UK./p/div
Zyprexa (olanzapine): Use in Adolescents - Clinicians should consider potential long-term risks when prescribing to adolescents
Audience: Neuropsychiatric healthcare professionals
ROCKVILLE, Md., Jan. 30, 2010 -- Lilly and FDA notified
healthcare professionals of changes to the Prescribing Information
for Zyprexa related to its indication for use in adolescents (ages
13-17)... (Source: Drugs.com - Pharma News)
